© 2020 MJH Life Sciences and Contagion Live. All rights reserved.
© 2020 MJH Life Sciences™ and Contagion Live. All rights reserved.
October 28, 2020
A new study shows disproportionate impact of the virus to this group.
As researchers develop ways to assess the effects of the pandemic on criminal activity, a new report documents the impact on those incarcerated.
October 27, 2020
These vital cells that are recovered from COVID-19 patients might be able to help people with compromised immune systems due to cancer therapy or transplantation.
While they decided to discontinue this trial in hospitalized COVID-19 patients, Lilly is continuing their other trials with the medication for COVID-19 treatment.
A research team recently focused on how the pandemic intensifies the effects felt by those already marginalized or vulnerable, as it is the intersection of biological and socioecological factors.
October 26, 2020
Invasive C glabrata found to be most prevalent strain of Candida in stool of patients with C difficile infection, and likely resistant to caspofungin.
A glimpse into FDA advisor perspective just weeks before EUAs are anticipated to be sent.
The company is planning to move forward after receiving a recommendation from the DSMB to start up the trial again.
A case study examines a treatment for a hospitalized case of the virus.